The Team
The NewSpring Capital Investment Team is made up of 13 investment professionals with significant experience as private equity investors, operating managers and industry leaders, and is supported by NewSpring Capital Infrastructure. Each Investment Fund has a partner group of both fully dedicated partners and NewSpring Capital. The NewSpring Capital team is as follows:
NewSpring Capital Investment Professionals
NewSpring Capital Administration |
||
Michael A. DiPiano
Mr. DiPiano is a General Partner of NewSpring Ventures and the Managing Partner of NewSpring Capital. Prior to joining NewSpring Capital, Mr. DiPiano was a serial entrepreneur and investor. He led or co-led the investment into six companies in the business services, healthcare and information technology industries. During that time, he was affiliated with Safeguard Scientifics (NYSE:SFG) and their related Funds. Prior to 1996, he spent six years as a division CEO and director of Chemical Leaman Corporation. Mr. DiPiano started his career in 1980 with Baxter Healthcare Corporation (NYSE: BAX) where he held numerous positions culminating as Vice President responsible for Operations and Sales of the Industrial Scientific Products Division. He currently serves on the boards of Femme Pharma; the Mid-Atlantic Capital Alliance, formerly known as the Greater Philadelphia Venture Group, which is a trade association representing over 80 Mid-Atlantic based private equity funds with approximately $12 billion under management, where he served as the 2005 program year Chairman; NutriSystem (NASDAQ: NTRI); Prescient Applied Intelligences (OTC BB: PPID); Bluenog; and the University City Science Center, where he sits on the investment committee. E-mail: MDiPiano@NewSpringCapital.com
Marc R. Lederman
Mr. Lederman is a General Partner of NewSpring Ventures and a Partner of NewSpring Capital. He has an extensive background in finance, consulting and accounting. Prior to joining NewSpring Capital, he was a Manager in the Business Assurance and Advisory Services Group of Deloitte & Touche. During his tenure at Deloitte & Touche, he led various projects within the financial services and healthcare industries, including mergers and acquisitions engagements, consulting projects and financial statement audits. He currently serves on the boards of CorrectNet, LiquidHub, The FeedRoom, and RealTIME. Mr. Lederman previously served on the board of directors of InnaPhase until its sale to Thermo Electron Corporation (NYSE: TMO) in September 2004. Mr. Lederman is an active member of the region’s venture capital community. He serves on the Executive Committee of the Board of Directors of the Mid-Atlantic Capital Alliance, the Steering Committee of the Mid-Atlantic Capital Conference, and is a national judge for the Ernst & Young Entrepreneur of the Year Awards. He is also an active panelist and supporter of the regional universities’ entrepreneurial programs. Mr. Lederman was selected as one of the Philadelphia region's “40 Under 40” young business leaders in 2005 and in 2001 received PhillyTech Magazine's “30 Under 30” award. He received a B.S. in Accountancy, cum laude, from Villanova University and an MBA from The Wharton School of the University of Pennsylvania. In addition, Mr. Lederman is a Certified Public Accountant. E-mail: MLederman@NewSpringCapital.com
Glenn T. Rieger
Mr. Rieger is a General Partner of NewSpring Ventures and a Partner of NewSpring Capital. Prior to joining NewSpring in 2004, he was a co-founder and managing director of Cross Atlantic Capital Partners, inc., the management company that oversees the operations of three venture funds with over $350 million in assets under management. He oversaw the operations of Cross Atlantic’s U.S. activities out of its Radnor, PA office and worked closely with several portfolio companies, including: Ecount, Gain Capital, and Management Dynamics. Prior to Cross Atlantic, he was a Senior Vice President for Safeguard Scientifics (NYSE:SFE) in charge of business development. In this position, he developed and oversaw merger, acquisition, investment and exit opportunities for Safeguard. In addition, he served as a business partner and director for five of Safeguard's partnership companies. Prior to joining Safeguard, he was a managing director of a boutique investment banking firm specializing in mergers and acquisitions, and President and Chief Executive Officer of a $1 billion California savings bank that employed over 250 people. He sits on the Board of Directors of NitroSecurity, Profit Point and Smart Destinations. He is active in the local venture capital community and for the 2004 program year chaired the Greater Philadelphia Venture Group, a trade association representing more than 80 venture funds representing approximately $12 billion in assets under management. He is a graduate of Colby College and has an MBA from The Wharton School of the University of Pennsylvania. Email: GRieger@NewSpringCapital.com
NewSpring Health Capital
Brian G. Murphy
Mr. Murphy is a General Partner of NewSpring Health Capital, General Partner of NewSpring Ventures, and a Partner of NewSpring Capital, with more than 20 years of private equity, corporate management and development experience, focused primarily in health care services. He has a strong background in business strategy, investment structuring, organizational growth, and negotiation of mergers and acquisitions. Prior to NewSpring, he founded Acquisition Management Services, Inc. (AMS), a diversified corporate development advisory firm focusing on middle market companies. AMS closed more than 330 acquisitions for its buy side clients. He has also founded two venture-backed startups, WordWave, a legal court reporting and broadcast captioning leader which was sold to Merrill Corp., and Precyse Solutions, a provider of medical transcription and health information services to acute care hospitals. Previously, he held executive positions for several health care service companies, most notably NovaCare, Inc., Heritage Health Systems, and Partners National Health Plans. He is currently on the Board of RedPath Integrated Pathology, Habit Management, Cybershift, TMG Health, Othera Pharmaceuticals, RecoverCare, SongBird Hearing, Precyse Solutions and the Foundation Board of SUNY Cortland. He received a B.S. in science from the State University of New York at Cortland. E-mail: BMurphy@NewSpringCapital.com
Zev S. Scherl
Mr. Scherl is a General Partner of NewSpring Health Capital and NewSpring Capital, with significant experience in principal investing, corporate management and finance, focused exclusively in the life sciences and health care industries. Prior to NSH, he worked with Pequot Ventures, which manages venture funds in excess of $1 billion, within Pequot Capital, which manages approximately $8 billion. Within Pequot Ventures, he originated and successfully executed investments in emerging life sciences and health care companies, whose technologies include (but are not limited to) computational genomics, diabetes and orthopedics, and served on many corporate boards. Previously, he was a member of the health care investment team of Behrman Capital, a private equity investment firm managing over $700 million, where he originated, executed and actively managed health care investments, emphasizing leveraged buyouts. Before entering private equity in 1997, he served as Senior Director, Strategic Planning, for Value Health, the largest independent pharmacy and mental health benefit management company, where he structured multi-year contracts with leading pharmaceutical companies and executed key growth initiatives, prior to its successful sale to Columbia HCA. He also served as U.S. Manager, Pricing Policy at Merck & Co., and prior to that was in the investment banking group at Lehman Brothers. Mr. Scherl is currently a board member for AppTec Laboratory Services, Scandius BioMedical, Inc., EKR Therapeutics, Nitric BioTherapeutics, Core Essence Orthopaedics and Immune Control, Inc. He received a BA with honors in economics from Duke University and an MBA from Harvard Business School. E-mail: ZScherl@NewSpringCapital.com
NewSpring Mezzanine Capital
Steven D. Hobman
Mr. Hobman is a General Partner of NewSpring Mezzanine with more than 20 years of experience in the financing of middle-market and growth-stage companies. He has provided more than $400 million in such financing to these companies. He has been a commercial banker for 20 years at Meridian Bank, Progress Bank, and Comerica Bank. He founded TechBanc, the venture lending division of Progress Bank, which was purchased by Comerica Bank in 2002. He is also a co-founder of Ben Franklin/Progress Capital Fund, L.P. in 1998 and NewSpring Ventures, L.P. in 1999. He is on the board of directors of Eastern Technology Council, Early Stage East, Montgomery County Industrial Development Corporation, Neighborhood Health Agencies, Inc., American Compliance Systems, Inc., Rankin Corporation, The Matworks, LLC, Media Market Group and Thermacore International Inc. He is also on the Advisory Board of Penn State Great Valley. He holds an A.B. from Franklin and Marshall College and an MBA from West Chester University. E-mail: SHobman@NewSpringCapital.com
Andrew Panzo
Mr. Panzo is a General Partner of NewSpring Mezzanine with nearly 20 years of experience in investment banking, venture capital, and operational management. Most recently, he was Chairman and CEO of Stonepath Group, a publicly-traded, third-party logistics company. As CEO, he was responsible for raising $75 million to execute a strategic consolidation of the non-asset based logistics industry. Prior to Stonepath, he was CEO of Net Value Holdings, Inc., the predecessor to Stonepath. Prior to Net Value, he was CEO of Brightstreet.com, and the founder and CEO of American Maple Leaf Corporation, a merchant bank affiliated with Canadian Maple Leaf Corporation. He is on the Board of Directors for York Telecom. He has a B.S. in Finance from University of Connecticut and an MBA in Finance and International Business from Temple University. E-mail: APanzo@NewSpringCapital.com
NewSpring Capital Investment Professionals
Jonathan S. Schwartz
Mr. Schwartz is a Partner and Chief Financial Officer of NewSpring Capital, overseeing the financial and operational infrastructure of the NewSpring Capital family of funds. He is a CPA with more than 14 years of experience working with private equity, investment banking, and other asset management organizations. Prior to joining NewSpring, he was Director of Finance and Administration at EnerTech Capital, a $300 million venture capital firm. Previously he was a Senior Manager with Ernst & Young, where he provided accounting and business advisory services to clients in the financial services industry. He is a graduate of Tulane University A.B. Freeman School of Business. He is also a member of the American Institute of Certified Public Accountants, the Pennsylvania Institute of CPAs, and a board member of the Philadelphia Chapter of the Private Equity CFO Association. E-mail: JSchwartz@NewSpringCapital.com
Michael D. Poisel
Mr. Poisel is a Principal of NewSpring Ventures with more than 10 years of investing experience. Prior to joining NewSpring, he made private equity investments in enterprise software and business services for both Apax Partners and GE Capital. He also has entrepreneurial experience, having started an Internet strategy consulting firm and having worked for S1 Corporation (NASDAQ: SONE) while attending business school. He began his career in manufacturing operations for General Electric/Lockheed Martin and participated in the successful completion of several commercial and government satellite programs. He serves as the Chairman of the Board for Ripple Technologies and serves as a board member of Bluenog, iPipeline, and NCT. He graduated with honors in Mechanical Engineering from Rose-Hulman Institute of Technology, holds an M.S. in Systems Engineering from The Moore School of Engineering of the University of Pennsylvania, and has an M.B.A. in finance and entrepreneurial management from The Wharton School of Business of the University of Pennsylvania. E-mail: MPoisel@NewSpringCapital.com
Mr. Killackey is a Principal of NewSpring Mezzanine Capital. Before joining NewSpring, he spent 10 years as Founder and Managing Director of TRF Private Equity. Previously, Mr. Killackey spent eight years in commercial lending with TRF and CoreStates Financial Corporation. He holds a BA and a MBA from The Wharton School of The University of Pennsylvania. JKillackey@NewSpringCapital.com
Dr. Ratnam is a Senior Associate of NewSpring Capital having joined the firm in 2007. She has extensive experience in drug discovery and enabling life science technologies. Dr. Ratnam also has expertise in clinical drug development and Food and Drug Administration regulations. Her therapeutic domain knowledge, which spans oncology, anti-infective and metabolic diseases, was gained at large pharmaceutical companies and contract organizations. Dr. Ratnam has successfully worked with early-stage biotechnology companies to develop strategies to expand the utility of their platform technologies and seek new sources of funding. She has a Ph.D. from the Ohio State University and completed her postdoctoral training at the University of Pennsylvania. Dr. Ratnam also has an MBA from Columbia University. Email: KRatnam@NewSpringCapital.com
Mr. Jensen is an Asscoiate of NewSpring Capital having joined the firm in 2005. Prior to joining NewSpring Capital, Mr. Jensen was a Senior Analyst at AIG Global Investment Group where he helped manage a $6 billion private equity portfolio. At AIG Global Investment Group, he was responsible for evaluating, selecting and monitoring investment opportunities in the venture capital and leveraged buyout sectors. Mr. Jensen graduated magna cum laude from the University of Delaware with a B.S. in Business Administration with a concentration in Finance and a minor in Economics. E-mail: EJensen@NewSpringCapital.com
Mr. VeVerka is an Associate of NewSpring Capital having joined the firm in 2006. Most recently, Mr. VeVerka was an Investment Banking Analyst at Credit Suisse. In this role, he assisted on several transactions in the financial institutions and financial technology sectors where his primary responsibilities were financial modeling, due diligence and deal marketing. Prior to Investment Banking, Mr. VeVerka worked in Credit Suisse’s Information Technology division, where he worked closely with the Chief Technology Officer evaluating new technologies for the firm. While completing his degree, Mr. VeVerka spent two summers at Goldman Sachs and worked on the Chairman’s staff at American Financial Group / Chiquita Brands. Mr. VeVerka graduated from the University of Cincinnati’s honors business program with a B.S. in Business Administration with a concentration in Information Technology and minors in Finance and Real Estate. E-mail: AVeVerka@NewSpringCapital.com
Mr. Matt Plevelich is an Analyst at NewSpring Capital having joined the firm in 2008 after graduation from the George Washington University. While completing his degree, Mr. Plevelich spent considerable time as an intern in the Office of the Vice Chairman at Washington D.C.’s largest full-service investment bank, Ferris, Baker Watts, where he performed in depth research for high net worth clients. Mr. Plevelich also spent a summer as an intern at NewSpring Capital. Mr. Plevelich graduated magna cum laude with a B.B.A with a concentration in Finance and a designation as a Dean’s Scholar in Globalization.
E-mail: MPlevelich@NewSpringCapital.com
Ms. Schoemaker is a Senior Analyst of NewSpring Capital having joined the firm in 2008. Most recently, Ms. Schoemaker was a Senior Analyst at American Capital (NASDAQ: ACAS). In this role, she assisted in financial due diligence for buyout investments and sponsored finance transactions and was responsible for portfolio monitoring and valuations of portfolio companies. Prior to American Capital, Ms. Schoemaker worked in KPMG’s Philadelphia audit practice as a Senior Associate, where she worked primarily on healthcare, life science and information technology companies. Ms. Schoemaker graduated from University of Rhode Island’s business program with a B.S. in Business Administration with a concentration in Accounting and a minor in Leadership. Additionally, Ms. Schoemaker graduated cum laude from Villanova University with a Masters of Accounting and Consultancy. E-mail: ASchoemaker@NewSpringCapital.com
NewSpring Capital Administration
Ms. Tluczek is the Office Manager for NewSpring Capital, overseeing the administration of NewSpring Capital and NewSpring Ventures.
E-mail: MTluczek@NewSpringCapital.com
Ms. Egan is the Senior Accountant for NewSpring Capital. She joined NewSpring in 2006 with nearly 20 years of experience working in both the public and private accounting sectors. Prior to joining NewSpring Capital, she was an accountant for TL Ventures, which has over $1.4 billion under management. She is a graduate of West Chester University. E-mail: EEgan@NewSpringCapital.com
Ms. Blanchard is an Administrative Associate for NewSpring Capital.
E-mail: LBlanchard@NewSpringCapital.com
Ms. Reiser is an Administrative Associate for NewSpring Capital.
E-mail: MReiser@NewSpringCapital.com
